Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Systemic lupus erythematosus
•
Dermatology
Do you have concerns about the use of red light therapy in a patient with lupus?
Related Questions
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
How would you approach the treatment of an SLE patient with refractory mucocutaneous ulcerations and lichenoid skin eruption despite treatment with MMF, Aza, Benlysta, Saphnelo, Rituximab, and JAK inhibitors?
What is your approach for severe SCLE in patients unable to tolerate HCQ?
How do you manage recalcitrant tumid lupus in a patient with partial response to antimalarials and off-label apremilast, in the setting of coexisting MDS with significant neutropenia?
Would you switch azathioprine to a different immunosuppressant if a controlled patient with SLE develops melanoma and/or non-melanoma skin cancer?
How would you approach management of a young male patient with discoid lupus who has had minimal response to hydroxychloroquine (and subtherapeutic whole blood levels) who continues to use tobacco products?
What treatments have you found most effective for cholestatic pruritus?
How do you envision incorporating CAR-T therapy into your clinical practice?
In patients with possible early SLE or undifferentiated disease can multiomics be used to help predict what disease phenotype they will develop?
What considerations do you take when using prednisone in patients with systemic sclerosis?
